| Auteur | |
|---|---|
| jiraporn66 | 07 Dec 2021 - 05:49:51 |
| 470 Posts |
 After joining forces withReady to support all applications Play directly on all smartphones or web pages of all brands, so taking advantage of this is as much as continuouslySLOTfollowing the news on your website. it's simple. Play slotxoth with the free credits you receive to wait for the announcement from the website. It may lead even more without wasting your money so you can increase your winnings to play online slots the Joint Drug Patent Organization to allow 95 countries to produce and sell the anti-Covid drug "Paxlovid" at a low cost, Pfizer recently filed for approval for the drug with the US Food and Drug Administration. for use in an emergency On November 17, 2021, the AP news agency reported that Pfizer Inc., a major US drugmaker. It announced an agreement with the Joint Drug Patent Organization (MPP) to enable drugmakers in 95 countries to produce and sell the anti-COVID-19 drug Paxlovid at a lower cost. have to pay royalties by 95 countries licensed to produce Paxlovid It is a low- and middle-income country. Covering 53% of the world's population, it is worth noting that among the licensed countries There is no list of Thailand included. According to the report of Matichon As for Pfizer's Paxlovid, It is a type of protease inhibitor drug. It works in the same way as antiretroviral drugs for HIV. can degrade the enzymes of COVID-19 which is the part where the virus attaches to the human nose, throat and lungs. According to preliminary clinical trials, it can reduce the likelihood of hospitalization or death. of people with symptoms of COVID-19 infection The risk of serious illness was 89% in those who received the drug within 3 days, while those who received the drug within 5 days of symptoms reduced their chances of being hospitalized or dying by 85%. Recently, CNN reported that Pfizer is seeking an emergency approval for Paxlovid from the US Food and Drug Administration (FDA). If Pfizer is approved by the FDA Paxlovid pill will revolutionize the fight against coronavirus People who are at high risk can take this drug at home. without having to admin at the hospital first This therapy may help reduce the strain on the hospital system during the outbreak, according to CNBC. On the same day, Pfizer CEO Albert Burla said in a statement: “We are working as quickly as possible. to put this possible treatment in the hands of the patient. And we look forward to working with the US FDA. and other regulators around the world.” Burla had previously said that Pfizer plans to send Paxlovid data to the FDA. before thanksgiving |
  |
|
